Acute Pulmonary Embolism in Post COVID-19 Infection, A Case Report
Journal of Otorhinolaryngology and Facial Plastic Surgery,
Vol. 6 No. 1 (2020),
12 September 2020
,
Page 1-4
https://doi.org/10.22037/orlfps.v6i1.33790
Abstract
COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many centers have noticed a high number of venous thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia. COVID-19 infection is associated with high morbidity and mortality largely due to respiratory failure, with micro vascular pulmonary thrombosis or PE originating from the leg veins playing an additional important pathophysiological role. Having undiagnosed or untreated PE may worsen patient outcomes and use of empiric therapeutic anticoagulation in certain COVID patients who do not have PE/DVT has been advocated. Here, we report a cases of COVID-19, in which massive pulmonary thromboembolism (PTE) occurred a few days after discharge?
- Pulmonary embolism; COVID-19; Post discharge thromboprophylaxis.
How to Cite
References
Grubic AD, Ayazi S, Zebarjadi J, Tahmasbi H, Ayazi K, Jobe BA. COVID-19 outbreak and surgical practice: The rationale for suspending non-urgent surgeries and role of testing modalities. World J Gastrointest Surg 2020; 12(6): 259-68.
Pishgahi M, Ansari Aval Z, Hajimoradi B, Bozorgmehr R, Safari S, Yousefifard M. Massive Pulmonary Thromboembolism in Patients with COVID-19; Report of Three Cases. Arch AcadEmerg Med. 2020; 8(1):e58. Published 2020 May 16.
Fontana, Pierre &Casini, Alessandro & Robert-Ebadi, Helia&Glauser, Frédéric&Righini, Marc &Blondon, Marc. (2020). venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines. Swiss Medical Weekly. 150. 10.4414/smw.2020.20301.
Samsami M, Zebarjadi Bagherpour J, Tahmasbi H, Mohammadi Tofigh A, Shojaee SP, Hatamabadi H. Review of Unusual Presentations of COVID-19. J Otorhinolaryngol Facial Plast Surg 2020;6(1):1-5.
Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS‐CoV‐2 infection. ClinChem Lab Med. 2020; Epub ahead of print.
Samsami M, Zebarjadi Bagherpour J, Nematihonar B, Tahmasbi H. COVID-19 Pneumonia in Asymptomatic Trauma Patients; Report of 8 Cases. Arch Acad EmergMed. 2020; 8(1): e46.
Mohammadi Tofigh A, Shojaei SP, Zebarjadi Bagherpour J, Mirkheshti A, Tahmasebi H. Pneumothorax as an Ominous Side Effect in COVID-19 Patients under Mechanical Ventilation: Report of Seven Patients. J Cell Mol Anesth. 2020;5(3):202-5.
Roberts L.N., Whyte M.B., Georgiou L. Post-discharge venous thromboembolism following hospital admission with COVID-19 [published online ahead of print, 2020 Aug 3] Blood. 2020 doi: 10.1182/blood.2020008086. blood.2020008086
G. D. Barnes, A. Burnett, A. Allen et al., “Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum,” Journal of Thrombosis and Thrombolysis, 2020;50(1):72–81.
A. C. Spyropoulos, F. A. Anderson Jr., G. FitzGerald et al., “Predictive and associative models to identify hospitalized medical patients at risk for VTE,” Chest, 2011;140(3):706–4.
Klok F, Kruip M, van der Meer N et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; pii: S0049-3848(20).
Bikdeli B, Madhavan M, and Jimenez D et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am CollCardiol. 2020.
National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. 2018.
Kumar P, Mediwake R, Rhead C. A matter of time: duration and choice ofvenousthromboprophylaxis in patients diagnosed with COVID-19. Br J Hosp Med (Lond). 2020; 81:1–2.
- Abstract Viewed: 396 times
- PDF Downloaded: 271 times